In an effort to find YAP1 inhibitors, we screened 102 small molecules that were FDA-approved, in clinical trials, or druglike, and found that the BET inhibitor NHWD-870 strongly suppressed YAP1 expression and melanoma proliferation. Here, DNER is linked to melanoma.